
Where it all began: The origins of forestry, NZ’s third-largest export
Kaingaroa lies at the heart of New Zealand's forestry sector.
Kaingaroa lies at the heart of New Zealand's forestry sector.
A giant sandpile sits at the centre of the site where perimeter walls have been built.
Chunks wre torn off some chipmakers as a Chinese AI firm jolted tech shares.
Passengers could be stopped from flying for 'inappropriate' fashion or body art.
One of the country’s biggest agribusinesses wants to see Olivado liquidated.
US-listed Rocket Lab hit a record high, with its shares rising 30%.
Investors are trying to figure out what Trump's policies will mean for the markets.
The market still declined despite the corporate action.
Oil company with colourful past set for court as liquidator cites tough times for growers.
DAZN is buying Foxtel for A$3.4b, sparking Sky TV takeover rumours.
Trump is positioning himself as a white knight in response.
New trial by medtech start-up gives hope to people living with a time bomb in their head.
Shares in the company rose $1.05 or 2.77% to $38.90, its second-highest close.
With about 90,000 staff worldwide, BP indicated more jobs could be cut.
The deal is contingent on approval from a Michigan state district court judge.
Global engine maintenance problems have stretched the airline's domestic network.
Auckland airport, Tourism Holdings and Millennium and Copthorne Hotels NZ all rose.
Inland Revenue confirmed a busy start to the year with the number of court applications.
The rise comes as latest data shows the economy is slowly recovering.
The social media platform is facing a US law change that would require Chinese divestment.
Financial Times: Zuckerberg escalates push to curry favour with Trump.
Printer Webstar is owed $67,000, trade creditors $28,000; the total owed is $95,000.
Kiwi company failed to get backing for continued US Medicare payments for its cancer test.
OPINION: And how will Trump's tariff plans pan out?
The UK grocer has successfully fought back against discount rivals.
'We see New Zealand as a long-term strategy.
The decline comes after the index was up 11.4% in 2024.
$500 million scheme from New Jersey to New Zealand rorted cancer-testing money.
The New Zealand stock exchange reported a decline as overseas markets led the way.